Nuvectis Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-9.5M | $-9.5M | — | $1.9M |
| FY2022 | $-13.6M | $-13.6M | — | $1.7M |
| FY2023 | $-16.0M | $-16.0M | — | $4.7M |
| FY2024 | $-12.2M | $-12.2M | — | $4.9M |
| FY2025 | $-16.0M | $-16.0M | — | $6.0M |